Megestrol Acetate Suspension
Product Images NDC 24979-041

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Megestrol Acetate (NDC 24979-041). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Upsher-smith Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

B5862d67-figure-01 (B5862d67 Figure 01)

Chemical structure of the active ingredient megestrol acetate, showing its steroidal backbone with multiple rings, methyl groups, and acetate functional groups.*

FDA Label Image

B5862d67-figure-02 (B5862d67 Figure 02)

A line graph titled 'TRIAL 1' showing mean weight change in kilograms on the vertical axis and time in weeks on the horizontal axis. The graph compares weight change over 12 weeks for groups receiving Megestrol Acetate at doses of 800 mg, 400 mg, 100 mg, and a placebo. Each dose group is represented by a different line with symbols, illustrating increasing weight change with higher doses over time.*

FDA Label Image

B5862d67-figure-03 (B5862d67 Figure 03)

A line graph titled 'TRIAL 2' depicting mean weight change (kg) over a 12-week period. The x-axis represents weeks (0 to 12), and the y-axis shows mean weight change in kilograms (-1 to 6). Two lines compare weight changes for groups labeled '800 mg' and 'Placebo.' The 800 mg group shows an increasing trend in weight, while the placebo group shows a decrease toward the end of the study.*

FDA Label Image

B5862d67-figure-04 (B5862d67 Figure 04)

FDA Label Image

05 (B5862d67 Figure 05)

Label for Megestrol Acetate Oral Suspension, USP 625 mg/5 mL (125 mg/mL) concentrated formula in a 150 mL bottle. The label includes dosage instructions, storage conditions, cautions, and manufacturing information for Upsher-Smith Laboratories, LLC, with NDC 24979-041-13. It is for prescription use only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.